Hi-Clearance Inc.
Research Hi-Clearance Inc. (1788.TWO) on Bullrun: market cap TWD 5.70B, P/E 14.5, dividend yield 5.6%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker1788.TWO
- ExchangeTWO
- CountryTaiwan
- SectorHealthcare
- IndustryMedical Devices
- CurrencyTWD
- Market capTWD 5.70B
- P/E14.5
- Dividend yield5.6%
- Financial periodQ2 2026
- RevenueTWD 1.11B
- Net incomeTWD 101.84M
- Free cash flowTWD 89.14M
- Gross margin28.4%
Valuation Snapshot
latest market cap is TWD 5.70B; P/E is 14.5; dividend yield is 5.6%.
Peer valuation comparison
Latest P/E is 14.55x versus a Healthcare sector median of 21.8x (33.3% below).
Latest dividend yield is 5.56% versus a Healthcare sector median of 2.4% (131.7% above).
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | TWD 5.70B | 14.5 | 5.5% | 7 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 7 TWD, yield 5.6%.
About Hi-Clearance Inc.
Hi-Clearance Inc. supplies medical devices for the renal, cardiac, radiation, dentistry, oral surgery, thoracic, respiratory, and metabolism markets in Taiwan. The company offers dialyzers, dialysis and, RO machines, and related consumables and drugs; interventional cardiology and radiology, and plastic surgery devices; dentistry consumables, implant materials, and equipment; and blood glucose monitors, and related consumables and nutrition products, as well as hemodialysis management services.
ETFs that hold Hi-Clearance Inc.
US-listed ETFs
Hi-Clearance Inc. is held by 3 US-listed ETFs, going by the latest portfolios they filed with the SEC, most traded first:
| ETF | Weight | Fee |
|---|---|---|
| Dimensional Emerging Markets Core Equity 2 ETF (DFEM) | <0.01% | 0.39% |
| Dimensional World ex U.S. Core Equity 2 ETF (DFAX) | <0.01% | 0.28% |
| Dimensional Emerging Markets Value ETF (DFEV) | <0.01% | 0.43% |
Portfolios as filed with the SEC on Form N-PORT, dated July 2026. Brokers in the EU generally do not offer US-listed ETFs to retail investors.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Hi-Clearance Inc.'s market cap?
Hi-Clearance Inc.'s market capitalization is TWD 5.70B.
What is Hi-Clearance Inc.'s P/E ratio?
Hi-Clearance Inc.'s price-to-earnings (P/E) ratio is 14.5.
Does Hi-Clearance Inc. pay a dividend?
Hi-Clearance Inc. has a dividend yield of 5.6%.
What does Hi-Clearance Inc. do?
Hi-Clearance Inc. supplies medical devices for the renal, cardiac, radiation, dentistry, oral surgery, thoracic, respiratory, and metabolism markets in Taiwan. The company offers dialyzers, dialysis and, RO machines, and related consumables and drugs; interventional cardiology and radiology, and plastic surgery devices; dentistry consumables, implant materials, and equipment; and blood glucose monitors, and related consumables and nutrition products, as well as hemodialysis management services.